New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export HIND’s income statement to Excel — free account
Vyome Holdings, Inc.
HINDVyome Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $319,700.00, up 24.4% from fiscal 2024.
- Revenue
- +67.6%
- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
1.20
0.25
−17.24%
Follow HIND
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 0.00% in Q3 FY26, the highest of these four quarters.
ROEROIC
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | 3263.0% | −235.8% | −172.1% | −71.8% |
| ROIC | 0.0% | 0.0% | 0.0% | 0.0% |
Debt
Net debt is 6.49× a year’s EBITDA. Debt is 0.05× equity, against 0.07× in Q4 FY25.
Debt / equityNet debt / EBITDA
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Debt / equity | 0.1× | 0.0× | 0.0× | 0.1× |
| Net debt / EBITDA | 3.5× | 7.8× | 9.2× | 6.5× |
Per share, from Q4 FY25
Since Q4 FY25, per share: revenue has fallen 59.9%; book value has grown 45.9%.
RevenueBook value
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | 1.0× | 0.4× | 0.3× | 0.4× |
| Book value | 1.0× | 1.9× | 1.6× | 1.5× |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 4 | 4 |
+8 more TTM periods Free account |
| (71.85%) | (172.10%) | (235.80%) | 3,262.99% | ||
| (48.02%) | (124.23%) | (131.16%) | (260.50%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(67.45%) | (178.61%) | (154.77%) | (373.24%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.64) | (0.79) | (0.74) | (0.64) | |
Free Cash Flow |
(4.49) | (5.58) | (4.98) | (3.75) | |
| Other line items | |||||
Cash ROIC |
(32.41%) | (36.70%) | (29.59%) | (41.70%) | |
Accounts Payable Turnover |
0.05 | 0.05 | 0.05 | 0.09 | |
Average Days of Payables |
4,936.88 | 6,335.40 | 5,713.24 | 4,649.96 | |
Research and Development Expense of Revenue |
1,280.16% | 1,225.81% | 762.11% | 183.99% | |
Selling, General and Administrative Expense of Revenue |
1,614.95% | 2,067.03% | 1,690.77% | 739.68% | |
Share Based Compensation of Revenue |
212.53% | 5,102.85% | 4,345.22% | 2,069.67% | |
Interest Coverage |
(231.15) | (286.58) | (120.59) | (71.30) | |
Operating CF/Net income |
1.19 | 0.49 | 0.46 | 0.37 | |
Depreciation/Fixed assets |
0.26 | 0.25 | 0.25 | 0.26 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.02 | 0.02 | 0.02 | 0.05 | |
Operating CF per Share |
(0.64) | (0.79) | (0.74) | (0.64) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated Nov 18, 2026